Explore the Global Tuberculosis The Global rapeutics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Tuberculosis Therapeutics Market

Key Insight

Tuberculosis therapeutics sales will rise through 2036, driven by active TB at 61.3% of the disease type segment in 2026, supported by persistent global TB burden and expanding access to diagnostics and treatment. The market was valued at USD 1.40 billion in 2025 and is expected to be worth USD 2.98 billion by 2036.

May 12, 2026

Anurag Sharma

250 Pages

Cite this Report

Tuberculosis Therapeutics Market

https://www.futuremarketinsights.com/reports/tuberculosis-therapeutics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

BlackRock
Eli Lilly and Company
GSK
The Vanguard Group
Lupin
Merck KGaA
Novartis
Otsuka Pharmaceutical Co. Ltd
Panacea Biotec Ltd
L'Oréal
SunPharmaceuticals Industries Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Tuberculosis Therapeutics Market

Key Players

Similar Industry Reports